Greenberg Traurig to Sponsor and Shareholder Lori Cohen to Speak at DRI’s Drug and Medical Device Seminar

Share Article

Greenberg Traurig, LLP will sponsor and Shareholder Lori G. Cohen will speak at the Defense Research Institute’s (DRI) 31st Annual Drug and Medical Device Seminar taking place May 14-15, 2015 in San Francisco, California.

Greenberg Traurig, LLP will sponsor and Shareholder Lori G. Cohen will speak at the Defense Research Institute’s (DRI) 31st Annual Drug and Medical Device Seminar taking place May 14-15, 2015 in San Francisco, California.

Cohen will speak on a panel May 14, 2015 at 11:15 a.m. entitled “Call 1-800-Bad Drug: Plaintiff Lawyer Advertising.” She is a member of the DRI Drug and Device Steering Committee and served as the chair of the 2014 DRI Drug and Device Annual Meeting.

According to DRI, it is the leading organization of defense attorneys and in-house counsel. DRI is host to 30 substantive committees whose focus is to develop ongoing and critical dialogue about areas of practice. DRI has served the defense bar for more than 50 years and focuses on five main goals: education, justice, balance, economics, and professionalism and service.

Cohen is chair of Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Practice and Trial Practice. She has a national litigation practice focusing on product liability litigation and specifically, medical device and pharmaceutical litigation. She is widely recognized for her trial skills, having received 56 defense verdicts at trial. She was profiled in Law360’s 2012 "Top Female Trial Attorneys," the Financial Times, and The National Law Journal’s “Winning - Successful Strategies From Some of the Nation’s Top Litigators,” a special report recognizing 10 attorneys from across the United States. The National Law Journal recognized Cohen as one of "The 50 Most Influential Women Lawyers in America” and recognized two of her defense trial victories as “Top Defense Wins” in recent years. Cohen has also been recognized by Georgia Super Lawyers magazine as one of its "Top 10 Georgia Super Lawyers" for the last three years, and one of the "Top 100 Georgia Super Lawyers" and "Top 50 Female Georgia Super Lawyers" for the last 11 years. In addition, she is one of a very small group of attorneys selected nationally for inclusion in the 2010-2014 editions of Chambers and Partners USA Guide's national Pharmaceutical Industry Products Liability Table.

About Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Practice

The Pharmaceutical, Medical Device & Health Care Litigation Practice is an integral part of the firm’s 600-plus member national Litigation Practice. The team is nationally recognized for its dynamic courtroom presence, responsiveness to clients, and deep subject matter knowledge. Recent recognitions include national rankings for 2014 “Products Liability & Mass Torts” from Chambers USA Guide; national rankings for 2014 “Practice Liability & Mass Torts Defense: Pharmaceuticals and Medical Devices” from The Legal 500 United States; and a first-tier national ranking for "Litigation – Mass Tort Litigation and Class Actions – Defendants" from U.S. News – Best Lawyers® 2015 Best Law Firms. In addition, Greenberg Traurig is recognized as a "Product Liability Litigation Standout" in the BTI Litigation Outlook 2015 published by BTI Consulting Group.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 1,800 attorneys serving clients from 37 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is among the “Power Elite” in the 2014 BTI Client Relationship Scorecard report, which assesses the nature and strength of law firms' client relationships. For additional information, please visit http://www.gtlaw.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo-Martinez
Greenberg Traurig
+1 212-801-2131
Email >
@GT_Law
Follow >
Greenberg Traurig, LLP

Visit website